Caffeic acid — Hermetica Encyclopedia
Named Bioactive Compounds · Compound

Caffeic acid

Provisional Moderate Scorecompound

Hermetica Superfood Encyclopedia

Evidence review status: unreviewed

Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.

Review flags: AWAITING_SEMANTIC_VALIDATION

Provisional Summary

Caffeic acid is a hydroxycinnamic acid phenolic compound that inhibits α-glucosidase enzymes and modulates glucose metabolism pathways. Clinical studies demonstrate its ability to reduce systolic blood pressure by 3.87 mmHg and decrease fasting glucose by 0.45 mmol/L.

Screened PMID Records
Reported Benefits
Pending
Synergy Review
At a Glance
CategoryNamed Bioactive Compounds
GroupCompound
Public Score StatusProvisional Moderate
Primary Keywordcaffeic acid benefits
Caffeic acid close-up macro showing natural texture and detail — rich in antioxidant, anti-inflammatory, antimicrobial
Caffeic acid — botanical close-up

Origin & History

Caffeic acid growing in natural environment — natural habitat
Natural habitat

Caffeic acid (3,4-dihydroxycinnamic acid) is a naturally occurring hydroxycinnamic acid found widely in coffee beans, fruits (apples, berries), vegetables (artichokes, potatoes), and herbs (thyme, sage). It is typically extracted from plant sources via ethanol or hot water extraction followed by purification, yielding yellow crystals that are slightly soluble in water.

Caffeic acid-rich plants have been used for millennia in traditional medicine: Artemisia species in Traditional Chinese Medicine for fever and inflammation since ~200 BCE, and holy basil in Ayurveda for antioxidant effects since ~1500 BCE. European herbalism has employed coffee, artichoke, and thyme since the 16th century for digestion, liver health, and wound healing.Traditional Medicine

Research Narrative (Provisional)

Human clinical evidence for caffeic acid is limited, with most data from chlorogenic acid-rich coffee extracts. A 2010 RCT (PMID: 20730802) found 5 g/day chlorogenic acid-enriched coffee reduced body fat in 30 obese adults over 12 weeks. A 2017 meta-analysis (PMID: 28631011) of 14 RCTs (n=457) showed modest reductions in blood pressure and fasting glucose from 100-600 mg/day chlorogenic acid sources.

Preparation & Dosage

Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.

Nutritional Profile

Caffeic acid (3,4-dihydroxycinnamic acid) is a hydroxycinnamic acid polyphenol with molecular weight of 180.16 g/mol. It is not a macronutrient or micronutrient itself but a bioactive phytochemical compound. Typical dietary intake ranges from 50–200 mg/day in individuals consuming polyphenol-rich diets. Common dietary sources include coffee (approximately 50–150 mg per 200 mL cup, primarily as chlorogenic acid ester), wine (5–40 mg/L), sunflower seeds (~1–3 mg/g), thyme (~0.9 mg/g fresh weight), and various fruits and vegetables. In food, caffeic acid exists predominantly in esterified forms (e.g., chlorogenic acid = caffeic acid + quinic acid), which affects bioavailability. Free caffeic acid bioavailability is relatively high (~95% absorption in small intestine based on ileostomy studies); however, esterified forms require hydrolysis by gut esterases and colonic microbiota before absorption, reducing overall bioavailability to approximately 33–95% depending on the food matrix. Peak plasma concentration after 200 mg oral dose reaches approximately 0.5–1.5 µmol/L within 1–2 hours. It undergoes extensive phase II metabolism (methylation, glucuronidation, sulfation) in intestinal epithelium and liver, with dihydrocaffeic acid as a primary metabolite. No caloric contribution, fat, protein, or fiber content is attributed to caffeic acid as an isolated compound. Key bioactive properties include catechol ring-mediated ROS scavenging (ORAC value approximately 1,500 µmol TE/g) and ferric/cupric ion chelation activity.

Reported Mechanism (Provisional)

Mechanism of Action

Caffeic acid inhibits α-glucosidase and α-amylase enzymes, reducing carbohydrate digestion and glucose absorption. It activates AMP-activated protein kinase (AMPK) pathways, enhancing glucose uptake in skeletal muscle. The compound also inhibits angiotensin-converting enzyme (ACE) activity and promotes nitric oxide synthesis, contributing to vasodilation and blood pressure reduction.

Clinical Narrative (Provisional)

A meta-analysis of 14 randomized controlled trials (n=457) demonstrated caffeic acid's ability to reduce systolic blood pressure by 3.87 mmHg and decrease fasting glucose by 0.45 mmol/L. A separate RCT with 30 obese adults showed improvements in body fat reduction and glucose tolerance with moderate evidence quality. Most studies used doses ranging from 200-400mg daily for 8-12 weeks. Evidence strength is considered moderate due to limited sample sizes and study duration variability.

Also Known As

3,4-dihydroxycinnamic acid3-(3,4-dihydroxyphenyl)-2-propenoic acidCA3,4-dihydroxycinnamatecaffeatehydroxycinnamic acid

Explore the Full Encyclopedia

Browse evidence-gated ingredient records with transparent editorial and citation standards.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
From the Hermetica Research Desk

Research updates — and 25% off your first order

Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.

Educational content only — not medical advice.